Literature DB >> 28130578

[Liver metastases of colorectal cancer].

R-T Hoffmann1.   

Abstract

Liver metastases are the most common cause of death in colorectal cancer patients. Nowadays, complete resection is considered to be the only curative treatment but only approximately 25% of patients are suitable candidates for surgery; therefore, many different interventional oncology techniques have been developed in recent years for the treatment of secondary liver metastases. The aim of interventional oncological procedures is either to provide a potentially curative treatment option for locally limited metastases with local ablative techniques, to enable nonresectable tumors to become accessible to surgical or local ablative techniques using transarterial procedures or to achieve improved survival in a palliative setting. These interventional therapies include transarterial approaches, such as chemoembolization and radioembolization as well as a multitude of different ablative techniques, such as radiofrequency and microwave ablation as well as irreversible electroporation (IRE). This article describes the indications for the various procedures and the clinical results of each of these techniques are reviewed based on the currently available literature.

Entities:  

Keywords:  Interventional oncology; Radioembolization; Radiofrequency ablation; Thermal ablation; Transarterial chemoembolization

Mesh:

Year:  2017        PMID: 28130578     DOI: 10.1007/s00117-017-0208-0

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  50 in total

1.  Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.

Authors:  Andrew S Kennedy; David Ball; Steven J Cohen; Michael Cohn; Douglas M Coldwell; Alain Drooz; Eduardo Ehrenwald; Samir Kanani; Steven C Rose; Charles W Nutting; Fred M Moeslein; Michael A Savin; Sabine Schirm; Samuel G Putnam; Navesh K Sharma; Eric A Wang
Journal:  J Gastrointest Oncol       Date:  2015-04

2.  Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.

Authors:  Chusilp Charnsangavej; Bryan Clary; Yuman Fong; Axel Grothey; Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2006-09-01       Impact factor: 5.344

Review 3.  Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.

Authors:  Minzhi Xing; David A Kooby; Bassel F El-Rayes; Nima Kokabi; Juan C Camacho; Hyun S Kim
Journal:  J Surg Oncol       Date:  2014-04-24       Impact factor: 3.454

4.  Hepatic ablation using radiofrequency electrocautery.

Authors:  J P McGahan; P D Browning; J M Brock; H Tesluk
Journal:  Invest Radiol       Date:  1990-03       Impact factor: 6.016

5.  Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma.

Authors:  T Shibata; T Niinobu; N Ogata; M Takami
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

6.  Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry.

Authors:  R C G Martin; J Howard; D Tomalty; K Robbins; R Padr; P M Bosnjakovic; Cliff Tatum
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-27       Impact factor: 2.740

7.  Incidence and treatment of local site recurrences following RFA of colorectal liver metastases.

Authors:  Karin Nielsen; Aukje A J M van Tilborg; Martijn R Meijerink; Matessa O Macintosh; Babs M Zonderhuis; Elly S M de Lange; Emile F I Comans; Sybren Meijer; M Petrousjka van den Tol
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

8.  TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects.

Authors:  Giammaria Fiorentini; Camillo Aliberti; Giorgio Benea; Francesco Montagnani; Andrea Mambrini; Pier Luigi Ballardini; Maurizio Cantore
Journal:  Hepatogastroenterology       Date:  2008 Nov-Dec

Review 9.  Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases.

Authors:  Alan Alper Sag; Fatih Selcukbiricik; Nil Molinas Mandel
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

View more
  1 in total

1.  Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex.

Authors:  Rui Zhang; Jian Xu; Jian Zhao; Jinghui Bai
Journal:  Oncotarget       Date:  2017-07-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.